OTC:INLB Item 9 Labs (INLB) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About Item 9 Labs Stock (OTC:INLB) 30 days 90 days 365 days Advanced Chart Get Item 9 Labs alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume500 shsAverage Volume13.46 million shsMarket Capitalization$70 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona. Read More Receive INLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Item 9 Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address INLB Stock News HeadlinesItem 9 Labs Corp Stock Price Today | OTC: INLB Live - Investing.comJune 29, 2025 | investing.comItem 9 Labs CorpJanuary 4, 2024 | morningstar.comMThis Crypto Is Set to Explode in JanuaryBillions Flowing Into Crypto (Here’s Where It’s Going!) Institutional money is flooding into crypto... Discover which coins they’re buying at the Crypto Hedge Fund Summit, before prices catch up.August 2 at 2:00 AM | Crypto 101 Media (Ad)Item 9 Labs Corp. Retains Sharp Capital Advisors to Facilitate a Sale of the BusinessDecember 19, 2023 | finance.yahoo.com'The Jewel In The Crown': How Data Is Shaping Cannabis Retail, 'Customers Are Key', Says Item 9 Labs CEOAugust 11, 2023 | markets.businessinsider.comINLB Item 9 Labs Corp.August 9, 2023 | seekingalpha.com'We're Owned By People From The Community," Says Item 9 Labs Corp CEO On Its Franchise ModelAugust 3, 2023 | benzinga.comItem 9 Labs announces restructuring to cut costsMay 23, 2023 | msn.comSee More Headlines INLB Stock Analysis - Frequently Asked Questions How were Item 9 Labs' earnings last quarter? Item 9 Labs Corp. (OTC:INLB) posted its earnings results on Monday, May, 16th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.03) by $0.01. How do I buy shares of Item 9 Labs? Shares of INLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Item 9 Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Item 9 Labs investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Meta Platforms (META), Pfizer (PFE), PayPal (PYPL), Teladoc Health (TDOC) and Adobe (ADBE). Company Calendar Last Earnings5/16/2022Today8/02/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTC SectorMedical Industry Dental equipment & supplies Sub-IndustryMedical Equipment Current SymbolOTC:INLB CIK1500123 Webwww.item9labscorp.com Phone833-867-6337FaxN/AEmployees100Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$21.76 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares701,919,000Free Float562,848,000Market Cap$70 thousand OptionableNot Optionable Beta0.77 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (OTC:INLB) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredDon’t Touch Tesla Stock Without Reading This FirstJeff Brown says he wouldn’t touch Tesla stock right now—and the reason might shock you. A 40-year Wall Stre...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Item 9 Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Item 9 Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.